150 related articles for article (PubMed ID: 37304648)
1. miR 204-5p inhibits apoptosis in dacarbazine-treated melanoma cells.
Palkina N; Sergeeva E; Ruksha T
Oncol Res; 2021; 29(6):393-400. PubMed ID: 37304648
[TBL] [Abstract][Full Text] [Related]
2. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine.
Thangasamy T; Sittadjody S; Limesand KH; Burd R
Cell Oncol; 2008; 30(5):371-87. PubMed ID: 18791269
[TBL] [Abstract][Full Text] [Related]
4. [miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
Li J; Zhao R; Fang R; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1360-1365. PubMed ID: 30514686
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion alterations in G0-positive melanoma cells.
Esimbekova AR; Palkina NV; Zinchenko IS; Belenyuk VD; Savchenko AA; Sergeeva EY; Ruksha TG
Cancer Med; 2023 Mar; 12(6):7294-7308. PubMed ID: 36533319
[TBL] [Abstract][Full Text] [Related]
6. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
[TBL] [Abstract][Full Text] [Related]
7. miR-21-5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C.
Yang Z; Liao B; Xiang X; Ke S
FEBS Open Bio; 2020 May; 10(5):752-760. PubMed ID: 32090490
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF
BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391
[TBL] [Abstract][Full Text] [Related]
9. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
[TBL] [Abstract][Full Text] [Related]
10. Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
Risberg K; Fodstad O; Andersson Y
J Immunother; 2010 Apr; 33(3):272-8. PubMed ID: 20445347
[TBL] [Abstract][Full Text] [Related]
11. Dacarbazine inhibits proliferation of melanoma FEMX-1 cells by up-regulating expression of miRNA-200.
Chen YN
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1191-1197. PubMed ID: 28387914
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
[TBL] [Abstract][Full Text] [Related]
13. CircHIPK3 regulates melanoma cell behaviors by binding with miR-215-5p to upregulate YY1.
Zhu X; Sun J
Mol Cell Probes; 2020 Oct; 53():101644. PubMed ID: 32800940
[TBL] [Abstract][Full Text] [Related]
14. The curcumin analog DM-1 induces apoptotic cell death in melanoma.
Faião-Flores F; Suarez JA; Maria-Engler SS; Soto-Cerrato V; Pérez-Tomás R; Maria DA
Tumour Biol; 2013 Apr; 34(2):1119-29. PubMed ID: 23359272
[TBL] [Abstract][Full Text] [Related]
15. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
16. miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Vergani E; Dugo M; Cossa M; Frigerio S; Di Guardo L; Gallino G; Mattavelli I; Vergani B; Lalli L; Tamborini E; Valeri B; Gargiuli C; Shahaj E; Ferrarini M; Ferrero E; Gomez Lira M; Huber V; Del Vecchio M; Sensi M; Leone BE; Santinami M; Rivoltini L; Rodolfo M; Vallacchi V
Cell Commun Signal; 2020 Sep; 18(1):156. PubMed ID: 32967672
[TBL] [Abstract][Full Text] [Related]
17. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
Long J; Pi X
Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Wu J; Li J; Ren J; Zhang D
Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
[TBL] [Abstract][Full Text] [Related]
19. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
